For more information, refer to the comprehensive list of statements and comments to FDA.
REGULATORY UPDATE: FDA Expects IRA Final Guidance Before End of PHE
February 03, 2023
Peter Marks to Join Thursday Hot Topic Discussion on Individual Risk Assessment
February 01, 2023
REGULATORY UPDATE: FDA Releases 2023 Guidance Agenda
January 31, 2023